Epstein Secrets

Amendment to '11.R. 2486 - Access to Counsel Act of 2020', and Senate Amendment to 'H.R. 1957 - Great American Outdoors Act', plus consideration of 'H.R. 7573 - To direct the Architect of the Capitol to replace the bust of Roger Brooke Taney in the Old Supreme Court Chamber of the United States Capit

re Will Not Compromise Vaccine Safety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety

ct of 2020', as amended, 'S. 2258 - Criminal Antitrust Anti-Retaliation Act of 2019', 'H.R. 683 - PPRADA', 'S. 134 - Combat Online Predators Act', 'H.R. 8354 - Servicemembers and Veterans Initiative Act of 2020', as amended, 'S. 3989 - United States Semiquincentennial Commission Amendments Act of 2020

whose company "will be the exclusive manufacturer in mainland China for the vaccine made by the EFTA00135860 British-Swedish pharmaceutical giant AstraZeneca, and the companies could work together on deals for other countries. The Chinese company is also in early trials for its own candidate." The Times

Act of 2020', as amended, `S. 2258 — Criminal Antitrust Anti- Retaliation Act of 2019', 'H.R. 683 — PPRADA', 'S. 134 — Combat Online Predators Act', 'H.R. 8354 - Servicemembers and Veterans Initiative Act of 2020', as amended, 'S. 3989 — United States Semiquincentennial Commission Amendments Act of 20

l linked to Du, whose company "will be the exclusive manufacturer in mainland China for the vaccine made by the British-Swedish pharmaceutical giant AstraZeneca, and the companies could work together on deals for other countries. The Chinese company is also in early trials for its own candidate." The Times

ram Act of 2020; as amended, 'S. 2258 - Criminal Antitrust Anti-Retaliation Act of 201% 'H.R. 683 - PPRADA, 'S. 134 - Combat Online Predators Act, 'H.R. 8354 - Servicemembers and Veterans Initiative Act of 2020; as amended, 'S. 3989 — United States Semiquincentennial Commission Amendments Act of 202

linked to Du, whose company "will be the exclusive manufacturer in mainland China for the vaccine made by the British-Swedish pharmaceutical giant AstraZeneca, and the companies could work together on deals for other countries. The Chinese company is also in early trials for its own candidate." The Times

slation including 'H.R. 991 - Extension of the Caribbean Basin Economic Recovery Act, 'H.R. 2166 - Global Health Security Act of 2020; as amended, 'H.R. 4864 - Global Child Thrive Act of 2020; as amended, 'H.R. 5664 — Leveraging Information on Foreign Traffickers Act', as amended, 'S. 785 - Commander

re reaching the final goal of 164." Moderna won't "dive in until 53 cases have occurred; its ultimate goal is to make a judgment at 151 diagnoses." AstraZeneca will "take its first look at 75 cases, and not again until the trial is complete with 150." Federal Advisory Committee Postpones Vote On Vaccine Ro

and some other federal property under congressional control." The Washington Post (4/22, Flynn, 10.52M) reports that the bill, "symbolically titled H.R. 51, now heads to the Senate, where proponents hope to break new ground - including a first- ever hearing in that chamber." However, the Post says "t

on within just a few days." In his Washington Post (4/22, 10.52M) column, Fareed Zakaria argues the pause, and Europe's temporary suspension of the AstraZeneca vaccine, "are fueling many people's fears EFTA00150536 about vaccine safety, perpetuating conspiracy theories and wasting precious time at a momen

ation including 'H.R. 991 - Extension of the Caribbean Basin Economic Recovery Act', 'H.R. 2166 - Global Health Security Act of 2020', as amended, 'H.R. 4864 - Global Child Thrive Act of 2020', as amended, 'H.R. 5664 - Leveraging Information on Foreign Traffickers Act', as amended, 'S. 785 - Commander

re reaching the final goal of 164." Moderna won't "dive in until 53 cases have occurred; its ultimate goal is to make a judgment at 151 diagnoses." AstraZeneca will "take its first look at 75 cases, and not again until the trial is complete with 150." Federal Advisory Committee Postpones Vote On Vaccine Ro